Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1992 Dec 15;89(24):11832–11836. doi: 10.1073/pnas.89.24.11832

Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis.

B M Mueller 1, R A Reisfeld 1, T S Edgington 1, W Ruf 1
PMCID: PMC50651  PMID: 1465406

Abstract

Metastasis is a multistep process which requires highly adapted interactions of tumor cells with host target organs. Compared with nonmetastatic cells, metastatic human melanoma cells express 1000-fold higher level of tissue factor (TF), the major cellular initiator of the plasma coagulation protease cascades. To explore whether TF may contribute to metastatic tumor dissemination, we analyzed the effect of specific inhibition of TF function on human melanoma metastasis in severe combined immunodeficient (SCID) mice. Using species-specific antibodies to TF, we demonstrate that initial adherence in insufficient for successful tumor cell implantation in a target organ. Rapid arrest of human tumor cells in the lungs of mice was not diminished by inhibition of TF. However, inhibition of TF receptor function and consequent reduction in local protease generation abolished prolonged adherence of tumor cells, resulting in significantly reduced numbers of tumor cells retained in the vasculature of the lungs. The growth of pulmonary metastases was also significantly inhibited by a blocking anti-TF monoclonal antibody and Fab fragments thereof, whereas a noninhibitory antibody lacked antimetastatic effects. Cell surface expression of functional TF thus contributes to melanoma progression by allowing metastatic cells to provide requisite signals for prolonged adhesive interactions and/or transmigration of tumor cells across the endothelium, resulting in successful metastatic tumor implantation.

Full text

PDF
11832

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akslen L. A., Heuch I., Hartveit F. Metastatic patterns in autopsy cases of cutaneous melanoma. Invasion Metastasis. 1988;8(4):193–204. [PubMed] [Google Scholar]
  2. Aruffo A., Dietsch M. T., Wan H., Hellström K. E., Hellström I. Granule membrane protein 140 (GMP140) binds to carcinomas and carcinoma-derived cell lines. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2292–2296. doi: 10.1073/pnas.89.6.2292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bauer K. A., Conway E. M., Bach R., Konigsberg W. H., Griffin J. D., Demetri G. Tissue factor gene expression in acute myeloblastic leukemia. Thromb Res. 1989 Nov 1;56(3):425–430. doi: 10.1016/0049-3848(89)90255-7. [DOI] [PubMed] [Google Scholar]
  4. Burrows F. J., Haskard D. O., Hart I. R., Marshall J. F., Selkirk S., Poole S., Thorpe P. E. Influence of tumor-derived interleukin 1 on melanoma-endothelial cell interactions in vitro. Cancer Res. 1991 Sep 15;51(18):4768–4775. [PubMed] [Google Scholar]
  5. Butcher E. C. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell. 1991 Dec 20;67(6):1033–1036. doi: 10.1016/0092-8674(91)90279-8. [DOI] [PubMed] [Google Scholar]
  6. Chan B. M., Matsuura N., Takada Y., Zetter B. R., Hemler M. E. In vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells. Science. 1991 Mar 29;251(5001):1600–1602. doi: 10.1126/science.2011740. [DOI] [PubMed] [Google Scholar]
  7. Clark W. H. Tumour progression and the nature of cancer. Br J Cancer. 1991 Oct;64(4):631–644. doi: 10.1038/bjc.1991.375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Clauss M., Gerlach M., Gerlach H., Brett J., Wang F., Familletti P. C., Pan Y. C., Olander J. V., Connolly D. T., Stern D. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med. 1990 Dec 1;172(6):1535–1545. doi: 10.1084/jem.172.6.1535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cornil I., Man S., Fernandez B., Kerbel R. S. Enhanced tumorigenicity, melanogenesis, and metastases of a human malignant melanoma after subdermal implantation in nude mice. J Natl Cancer Inst. 1989 Jun 21;81(12):938–944. doi: 10.1093/jnci/81.12.938. [DOI] [PubMed] [Google Scholar]
  10. Coughlin S. R., Vu T. K., Hung D. T., Wheaton V. I. Characterization of a functional thrombin receptor. Issues and opportunities. J Clin Invest. 1992 Feb;89(2):351–355. doi: 10.1172/JCI115592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Crissman J. D., Hatfield J. S., Menter D. G., Sloane B., Honn K. V. Morphological study of the interaction of intravascular tumor cells with endothelial cells and subendothelial matrix. Cancer Res. 1988 Jul 15;48(14):4065–4072. [PubMed] [Google Scholar]
  12. Davie E. W., Fujikawa K., Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry. 1991 Oct 29;30(43):10363–10370. doi: 10.1021/bi00107a001. [DOI] [PubMed] [Google Scholar]
  13. Drake T. A., Morrissey J. H., Edgington T. S. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol. 1989 May;134(5):1087–1097. [PMC free article] [PubMed] [Google Scholar]
  14. Edgington T. S., Mackman N., Brand K., Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost. 1991 Jul 12;66(1):67–79. [PubMed] [Google Scholar]
  15. Ehrlich H. J., Gebbink R. K., Preissner K. T., Keijer J., Esmon N. L., Mertens K., Pannekoek H. Thrombin neutralizes plasminogen activator inhibitor 1 (PAI-1) that is complexed with vitronectin in the endothelial cell matrix. J Cell Biol. 1991 Dec;115(6):1773–1781. doi: 10.1083/jcb.115.6.1773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Esumi N., Fan D., Fidler I. J. Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor. Cancer Res. 1991 Sep 1;51(17):4549–4556. [PubMed] [Google Scholar]
  17. Fidler I. J. Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res. 1990 Oct 1;50(19):6130–6138. [PubMed] [Google Scholar]
  18. Francis J. L., Carty N., Amirkhosravi M., Loizidou M., Cooper A., Taylor I. The effect of Warfarin and factor VII on tissue procoagulant activity and pulmonary seeding. Br J Cancer. 1992 Mar;65(3):329–334. doi: 10.1038/bjc.1992.67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Gordon S. G., Franks J. J., Lewis B. Cancer procoagulant A: a factor X activating procoagulant from malignant tissue. Thromb Res. 1975 Feb;6(2):127–137. doi: 10.1016/0049-3848(75)90018-3. [DOI] [PubMed] [Google Scholar]
  20. Gunji Y., Gorelik E. Role of fibrin coagulation in protection of murine tumor cells from destruction by cytotoxic cells. Cancer Res. 1988 Sep 15;48(18):5216–5221. [PubMed] [Google Scholar]
  21. Hynes R. O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992 Apr 3;69(1):11–25. doi: 10.1016/0092-8674(92)90115-s. [DOI] [PubMed] [Google Scholar]
  22. Kadish J. L., Wenc K. M., Dvorak H. F. Tissue factor activity of normal and neoplastic cells: quantitation and species specificity. J Natl Cancer Inst. 1983 Mar;70(3):551–557. [PubMed] [Google Scholar]
  23. Karpatkin S., Pearlstein E., Ambrogio C., Coller B. S. Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. J Clin Invest. 1988 Apr;81(4):1012–1019. doi: 10.1172/JCI113411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Keck P. J., Hauser S. D., Krivi G., Sanzo K., Warren T., Feder J., Connolly D. T. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science. 1989 Dec 8;246(4935):1309–1312. doi: 10.1126/science.2479987. [DOI] [PubMed] [Google Scholar]
  25. Liotta L. A., Goldfarb R. H., Brundage R., Siegal G. P., Terranova V., Garbisa S. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res. 1981 Nov;41(11 Pt 1):4629–4636. [PubMed] [Google Scholar]
  26. McCulloch P., George W. D. Warfarin inhibition of metastasis: the role of anticoagulation. Br J Surg. 1987 Oct;74(10):879–883. doi: 10.1002/bjs.1800741005. [DOI] [PubMed] [Google Scholar]
  27. Morrissey J. H., Fair D. S., Edgington T. S. Monoclonal antibody analysis of purified and cell-associated tissue factor. Thromb Res. 1988 Nov 1;52(3):247–261. doi: 10.1016/0049-3848(88)90084-9. [DOI] [PubMed] [Google Scholar]
  28. Morrissey J. H., Revak D., Tejada P., Fair D. S., Edgington T. S. Resolution of monomeric and heterodimeric forms of tissue factor, the high-affinity cellular receptor for factor VII. Thromb Res. 1988 May 15;50(4):481–493. doi: 10.1016/0049-3848(88)90197-1. [DOI] [PubMed] [Google Scholar]
  29. Mueller B. M., Reisfeld R. A. Potential of the scid mouse as a host for human tumors. Cancer Metastasis Rev. 1991 Oct;10(3):193–200. doi: 10.1007/BF00050791. [DOI] [PubMed] [Google Scholar]
  30. Mueller B. M., Romerdahl C. A., Gillies S. D., Reisfeld R. A. Enhancement of antibody-dependent cytotoxicity with a chimeric anti-GD2 antibody. J Immunol. 1990 Feb 15;144(4):1382–1386. [PubMed] [Google Scholar]
  31. Mueller B. M., Romerdahl C. A., Trent J. M., Reisfeld R. A. Suppression of spontaneous melanoma metastasis in scid mice with an antibody to the epidermal growth factor receptor. Cancer Res. 1991 Apr 15;51(8):2193–2198. [PubMed] [Google Scholar]
  32. Murray J. C. Coagulation and cancer. Br J Cancer. 1991 Sep;64(3):422–424. doi: 10.1038/bjc.1991.325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Okoshi H., Hakomori S., Nisar M., Zhou Q. H., Kimura S., Tashiro K., Igarashi Y. Cell membrane signaling as target in cancer therapy. II: Inhibitory effect of N,N,N-trimethylsphingosine on metastatic potential of murine B16 melanoma cell line through blocking of tumor cell-dependent platelet aggregation. Cancer Res. 1991 Nov 15;51(22):6019–6024. [PubMed] [Google Scholar]
  34. Pober J. S., Cotran R. S. The role of endothelial cells in inflammation. Transplantation. 1990 Oct;50(4):537–544. doi: 10.1097/00007890-199010000-00001. [DOI] [PubMed] [Google Scholar]
  35. Rice G. E., Bevilacqua M. P. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science. 1989 Dec 8;246(4935):1303–1306. doi: 10.1126/science.2588007. [DOI] [PubMed] [Google Scholar]
  36. Ruf W., Edgington T. S. An anti-tissue factor monoclonal antibody which inhibits TF.VIIa complex is a potent anticoagulant in plasma. Thromb Haemost. 1991 Nov 1;66(5):529–533. [PubMed] [Google Scholar]
  37. Ruf W., Miles D. J., Rehemtulla A., Edgington T. S. Cofactor residues lysine 165 and 166 are critical for protein substrate recognition by the tissue factor-factor VIIa protease complex. J Biol Chem. 1992 Mar 25;267(9):6375–6381. [PubMed] [Google Scholar]
  38. Ruf W., Rehemtulla A., Edgington T. S. Antibody mapping of tissue factor implicates two different exon-encoded regions in function. Biochem J. 1991 Sep 15;278(Pt 3):729–733. doi: 10.1042/bj2780729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Rusciano D., Burger M. M. Why do cancer cells metastasize into particular organs? Bioessays. 1992 Mar;14(3):185–194. doi: 10.1002/bies.950140309. [DOI] [PubMed] [Google Scholar]
  40. Silberberg J. M., Gordon S., Zucker S. Identification of tissue factor in two human pancreatic cancer cell lines. Cancer Res. 1989 Oct 1;49(19):5443–5447. [PubMed] [Google Scholar]
  41. Smith G. F., Neubauer B. L., Sundboom J. L., Best K. L., Goode R. L., Tanzer L. R., Merriman R. L., Frank J. D., Herrmann R. G. Correlation of the in vivo anticoagulant, antithrombotic, and antimetastatic efficacy of warfarin in the rat. Thromb Res. 1988 Apr 1;50(1):163–174. doi: 10.1016/0049-3848(88)90184-3. [DOI] [PubMed] [Google Scholar]
  42. Weiss L., Orr F. W., Honn K. V. Interactions of cancer cells with the microvasculature during metastasis. FASEB J. 1988 Jan;2(1):12–21. doi: 10.1096/fasebj.2.1.3275560. [DOI] [PubMed] [Google Scholar]
  43. Welch D. R., Bisi J. E., Miller B. E., Conaway D., Seftor E. A., Yohem K. H., Gilmore L. B., Seftor R. E., Nakajima M., Hendrix M. J. Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line. Int J Cancer. 1991 Jan 21;47(2):227–237. doi: 10.1002/ijc.2910470211. [DOI] [PubMed] [Google Scholar]
  44. Zacharski L. R., Henderson W. G., Rickles F. R., Forman W. B., Cornell C. J., Jr, Forcier R. J., Harrower H. W., Johnson R. O. Rationale and experimental design for the VA Cooperative Study of Anticoagulation (Warfarin) in the Treatment of Cancer. Cancer. 1979 Aug;44(2):732–741. doi: 10.1002/1097-0142(197908)44:2<732::aid-cncr2820440246>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  45. Zhu D. Z., Cheng C. F., Pauli B. U. Mediation of lung metastasis of murine melanomas by a lung-specific endothelial cell adhesion molecule. Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9568–9572. doi: 10.1073/pnas.88.21.9568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Zhu D., Cheng C. F., Pauli B. U. Blocking of lung endothelial cell adhesion molecule-1 (Lu-ECAM-1) inhibits murine melanoma lung metastasis. J Clin Invest. 1992 Jun;89(6):1718–1724. doi: 10.1172/JCI115773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Zimmerman G. A., Prescott S. M., McIntyre T. M. Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol Today. 1992 Mar;13(3):93–100. doi: 10.1016/0167-5699(92)90149-2. [DOI] [PubMed] [Google Scholar]
  48. Zioncheck T. F., Roy S., Vehar G. A. The cytoplasmic domain of tissue factor is phosphorylated by a protein kinase C-dependent mechanism. J Biol Chem. 1992 Feb 25;267(6):3561–3564. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES